会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Camptothecin intermediates and method of making camptothecin and
comptothecin analogs
    • 喜树碱中间体和喜树碱和喜树碱类似物的制备方法
    • US5475108A
    • 1995-12-12
    • US114475
    • 1993-08-31
    • Daniel L. CominsMatthew F. Baevsky
    • Daniel L. CominsMatthew F. Baevsky
    • C07D491/052C07D491/22
    • C07D491/22
    • Disclosed are new methods of making camptothecin and camptothecin analogs defined by Formula I: ##STR1## wherein R is loweralkyl; R.sub.1 is H, loweralkyl, loweralkoxy, or halo; and R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are each independently H, amino, hydroxy, loweralkyl, loweralkoxy, loweralkylthiol, di(loweralkyl)amino, cyano, methylenedioxy, formyl, nitro, halo, trifluoromethyl, aminomethyl, azido, amido, hydrazino, or any of the twenty standard amino acids bonded to the A ring via the amino-nitrogen atom. The methods comprise cyclizing a compound of Formula IV: ##STR2## wherein X is Br or I, and Y is H, by an Aryl-to-Aryl free radical coupling reaction to yield a compound of Formula I. Compounds of Formula IV are made by alkylating a compound of Formula III: ##STR3## wherein R is loweralkyl and Y is H with a compound of Formula II-x: ##STR4## wherein X is a Br or I and V is hydroxy, by a Mitsunobu reaction to yield the compound of Formula IV.
    • 公开了由式I定义的喜树碱和喜树碱类似物的新方法:其中R是低级烷基; R1是H,低级烷基,低级烷氧基或卤素; 羟基,低级烷基,低级烷氧基,低级烷基硫醇,二(低级烷基)氨基,氰基,亚甲二氧基,甲酰基,硝基,卤素,三氟甲基,氨基甲基,叠氮基,酰氨基,肼基或 通过氨基 - 氮原子与A环结合的任何二十个标准氨基酸。 所述方法包括使式IV化合物:其中X是Br或I,Y是H,通过芳基 - 芳基自由基偶合反应来环化式IV化合物,得到式I化合物。式IV化合物是 通过将式III化合物:其中R是低级烷基并且Y是H,与式II-x的化合物:其中X是Br或I,V是羟基,通过 Mitsunobu反应得到式IV化合物。
    • 9. 发明授权
    • Method of making intermediates for camptothecin and its analogs
    • 制备喜树碱及其类似物的中间体的方法
    • US5478943A
    • 1995-12-26
    • US410729
    • 1995-03-27
    • Daniel L. CominsMatthew F. Baevsky
    • Daniel L. CominsMatthew F. Baevsky
    • C07D491/052C07D491/22
    • C07D491/22
    • Disclosed are new methods of making camptothecin and camptothecin analogs defined by Formula I: ##STR1## wherein R is loweralkyl; R.sub.1 is H, loweralkyl, loweralkoxy, or halo; and R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are each independently H, amino, hydroxy, loweralkyl, loweralkoxy, loweralkylthiol, di(loweralkyl)amino, cyano, methylenedioxy, formyl, nitro, halo, trifluoromethyl, aminomethyl, azido, amido, hydrazino, or any of the twenty standard amino acids bonded to the A ring via the amino-nitrogen atom. The methods comprise cyclizing a compound of Formula IV: ##STR2## wherein X is Br or I, and Y is H, by an Aryl-to-Aryl free radical coupling reaction to yield a compound of Formula I. Compounds of Formula IV are made by alkylating a compound of Formula III: ##STR3## wherein R is loweralkyl and Y is H with a compound of Formula II-x: ##STR4## wherein X is a Br or I and V is hydroxy, by a Mitsunobu reaction to yield the compound of Formula IV.
    • 公开了由式I定义的喜树碱和喜树碱类似物的新方法:其中R是低级烷基; R1是H,低级烷基,低级烷氧基或卤素; 羟基,低级烷基,低级烷氧基,低级烷基硫醇,二(低级烷基)氨基,氰基,亚甲二氧基,甲酰基,硝基,卤素,三氟甲基,氨基甲基,叠氮基,酰胺基,肼基或 通过氨基氮原子与A环结合的二十个标准氨基酸中的任一个。 所述方法包括使式IV化合物:其中X是Br或I,Y是H,通过芳基 - 芳基自由基偶合反应来环化式IV化合物,得到式I化合物。式IV化合物是 通过将式III化合物:其中R是低级烷基并且Y是H,与式II-x的化合物:其中X是Br或I,V是羟基,通过 Mitsunobu反应得到式IV化合物。